Dialysis News
- ACEIs, ARBs Safe to Continue in COVID-19: Trial Published
- When Packed Hospitals Cannot Handle Non-Covid Patients
- Medicare Coverage of Kidney Transplant Drugs Is Extended
- Dialysis Frequency Can Be Safely Reduced During Pandemic Under Certain Conditions
- The Lifesaving Potential of Less-Than-Perfect Donor Kidneys
- Kidney Dialysis Is a Booming Business. Is it Also a Rigged One?
- Dialysis Industry Emerges as Power Player in California Politics
- New CREDENCE Data Support SGLT2 Inhibitor Use in Advanced CKD
- New Guidelines Address Diabetes Management in Kidney Disease
- 'Kidney' vs 'Renal': Experts Say Words Matter
- COVID-19 Shortages Prompt Tough Decisions at Bedside
- First Tool to Specifically Assess Fatigue in Dialysis Is Validated
- KidneyWeek 2020 Study Supports Citrate Over Heparin Anticoagulation for Continuous Dialysis
- Protein Predicts Risk of AKI in COVID-19 Patients
- New Biomarkers Useful for Preventing, Managing Acute Kidney Injury
- Success of AV Fistulas for Dialysis Varies Between Countries
- HFSA 2020 Dapagliflozin's CKD Performance Sends Heart Failure Messages
- Death Knell for Phosphate Binders in Nondialysis CKD Patients?
- Acute Kidney Injury in COVID-19 Varies, but It Is Deadly
- EASD 2020 VERTIS CV: Ertugliflozin Benefit Falls Short of Other SGLT2 Inhibitors